Jeroen Dekervel

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Eileen Mary O'Reilly · 2 shared papers, 2024–2026 · strength 0.86
   • Paper ESMO podcast on upper GI cancers: highlights in hepatocellular carcinoma and pancreatic cancer from ESMO 2025. DOI 10.1016/j.esmogo.2025.100277↗
   • Paper Controversies in upper GI oncology: maintenance treatment in pancreatic cancer. DOI 10.1016/j.esmoop.2024.102244↗
2. Arndt Vogel · 1 shared paper, 2026 · strength 0.50
   • Paper ESMO podcast on upper GI cancers: highlights in hepatocellular carcinoma and pancreatic cancer from ESMO 2025. DOI 10.1016/j.esmogo.2025.100277↗
3. Baki Topal · 2 shared papers, 2020–2026 · strength 0.46
   • Paper Real-world feasibility and safety of neoadjuvant FOLFIRINOX in pancreatic ductal adenocarcinoma: a retrospective single… DOI 10.21037/jgo-2026-1-0041↗
   • Paper Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer. DOI 10.1016/j.tranon.2020.01.004↗
4. Nina Niu Sanford · 1 shared paper, 2025 · strength 0.42
   • Paper Controversies in upper gastrointestinal cancers-the role of radiotherapy in borderline resectable pancreatic cancer. DOI 10.1016/j.esmogo.2025.100232↗
5. Bas Groot Koerkamp · 1 shared paper, 2025 · strength 0.42
   • Paper Controversies in upper gastrointestinal cancers-the role of radiotherapy in borderline resectable pancreatic cancer. DOI 10.1016/j.esmogo.2025.100232↗
6. Daniel A. Laheru · 1 shared paper, 2024 · strength 0.36
   • Paper Controversies in upper GI oncology: maintenance treatment in pancreatic cancer. DOI 10.1016/j.esmoop.2024.102244↗
7. Soetkin D’Haens · 1 shared paper, 2026 · strength 0.36
   • Paper Real-world feasibility and safety of neoadjuvant FOLFIRINOX in pancreatic ductal adenocarcinoma: a retrospective single… DOI 10.21037/jgo-2026-1-0041↗
8. Halit Topal · 1 shared paper, 2026 · strength 0.36
   • Paper Real-world feasibility and safety of neoadjuvant FOLFIRINOX in pancreatic ductal adenocarcinoma: a retrospective single… DOI 10.21037/jgo-2026-1-0041↗
9. Ashenafi Shiferaw Bulle · 2 shared papers, 2019–2020 · strength 0.20
   • Paper Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer. DOI 10.1016/j.tranon.2020.01.004↗
   • Paper Gemcitabine induces Epithelial-to-Mesenchymal Transition in patient-derived pancreatic ductal adenocarcinoma xenografts. PMID 30899378↗
10. Jos F. van Pelt · 2 shared papers, 2019–2020 · strength 0.20
    • Paper Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer. DOI 10.1016/j.tranon.2020.01.004↗
    • Paper Gemcitabine induces Epithelial-to-Mesenchymal Transition in patient-derived pancreatic ductal adenocarcinoma xenografts. PMID 30899378↗
11. Chris Verslype · 2 shared papers, 2019–2020 · strength 0.20
    • Paper Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer. DOI 10.1016/j.tranon.2020.01.004↗
    • Paper Gemcitabine induces Epithelial-to-Mesenchymal Transition in patient-derived pancreatic ductal adenocarcinoma xenografts. PMID 30899378↗
12. Eric Van Cutsem · 2 shared papers, 2019–2020 · strength 0.20
    • Paper Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer. DOI 10.1016/j.tranon.2020.01.004↗
    • Paper Gemcitabine induces Epithelial-to-Mesenchymal Transition in patient-derived pancreatic ductal adenocarcinoma xenografts. PMID 30899378↗
13. Rekin’s Janky · 1 shared paper, 2020 · strength 0.10
    • Paper Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer. DOI 10.1016/j.tranon.2020.01.004↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.